Merck to Present at Goldman Sachs 32nd Annual Healthcare Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck's president and chief executive officer, is scheduled to present at the Goldman Sachs 32nd Annual Healthcare Conference in Rancho Palos Verdes, Calif., on June 8 at 4 p.m. PDT. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. An archive of the presentation will be available at the same location.

About Merck

Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com.



CONTACT:

Merck
Media:
Steven Campanini, 908-423-4291
or
Investor:
Carol Ferguson, 908-423-4465

KEYWORDS:   United States  North America  California  New Jersey

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Professional Services  Banking  Finance  Communications  Public Relations/Investor Relations  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.